The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer
JI Epstein, MB Amin, SW Fine… - … of pathology & …, 2021 - meridian.allenpress.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …
update grading recommendations. Data Sources.—Critical review of the literature along with …
Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive …
Context Pelvic lymph node dissection (PLND) yields the most accurate staging in patients
undergoing radical prostatectomy (RP) for prostate cancer (PCa), although it can be …
undergoing radical prostatectomy (RP) for prostate cancer (PCa), although it can be …
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …
risk stratification and workup, treatment options for localized disease, and management of …
Robot-assisted radical prostatectomy with the novel Hugo robotic system: initial experience and optimal surgical set-up at a tertiary referral robotic center
We describe the first five robot-assisted radical prostatectomies (RARPs) performed with the
new Hugo RAS system (Medtronic, Minneapolis, MN, USA) in Europe. The five patients …
new Hugo RAS system (Medtronic, Minneapolis, MN, USA) in Europe. The five patients …
A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic …
Background Available models for predicting lymph node invasion (LNI) in prostate cancer
(PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men …
(PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men …
Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
AD Combes, CA Palma, R Calopedos, L Wen, H Woo… - Diagnostics, 2022 - mdpi.com
Prostate cancer is the most common cancer and the second leading cause of cancer death
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
Outcomes of robot-assisted radical prostatectomy with the Hugo RAS surgical system: initial experience at a high-volume robotic center
CA Bravi, M Paciotti, E Balestrazzi, A Piro… - European Urology …, 2023 - Elsevier
Clinical data on robot-assisted radical prostatectomy (RARP) performed with the new Hugo
robot-assisted surgery (RAS) system are scarce. We described surgical outcomes of 112 …
robot-assisted surgery (RAS) system are scarce. We described surgical outcomes of 112 …
[HTML][HTML] External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the …
Background Different nomograms exist for the preoperative prediction of pelvic lymph-node
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …
External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node …
The 2019 Briganti nomogram was developed to calculate the risk of lymph node invasion
(LNI) and identify prostate cancer (PCa) patients diagnosed with magnetic resonance …
(LNI) and identify prostate cancer (PCa) patients diagnosed with magnetic resonance …